(Source: Macon Daily) Benefitfocus Inc logo Benefitfocus (NASDAQ:BNFT) had its price target reduced by Chardan Capital from $28.00 to $27.00 in a report released on Thursday. Chardan Capital currently has a neutral rating on the software maker’s stock. Other equities research analysts have also issued research reports about the stock.